Keith S. Manchester

CIK: 0001244828

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)16 (69.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (13.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (17.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ROIV

Roivant Sciences Ltd.

Director

Discretionary Trading P&L

Holdings

Transaction History (23 total)

ROIV
Roivant Sciences Ltd.
Sep 16, 2026
Award(A)
Direct
5.1K shares-
ROIV
Roivant Sciences Ltd.
Feb 13, 2026
Sale(S)
Indirect
225K shares at avg. $26.50$6.0M
ROIV
Roivant Sciences Ltd.
Feb 13, 2026
Sale(S)
Indirect
150.8K shares at avg. $26.49$4.0M
ROIV
Roivant Sciences Ltd.
Feb 12, 2026
Sale(S)
Indirect
275K shares at avg. $26.76$7.4M
ROIV
Roivant Sciences Ltd.
Feb 12, 2026
Sale(S)
Indirect
150K shares at avg. $26.72$4.0M
ROIV
Roivant Sciences Ltd.
Feb 11, 2026
Sale(S)
Indirect
425K shares at avg. $26.67$11.3M
ROIV
Roivant Sciences Ltd.
Dec 17, 2025
Sale(S)
Indirect
155.1K shares at avg. $23.02$3.6M
ROIV
Roivant Sciences Ltd.
Dec 17, 2025
Sale(S)
Indirect
432.7K shares at avg. $23.05$10.0M
ROIV
Roivant Sciences Ltd.
Dec 17, 2025
Sale(S)
Indirect
189.5K shares at avg. $23.17$4.4M
ROIV
Roivant Sciences Ltd.
Dec 16, 2025
Sale(S)
Indirect
642.3K shares at avg. $23.08$14.8M
ROIV
Roivant Sciences Ltd.
Dec 16, 2025
Sale(S)
Indirect
275K shares at avg. $22.93$6.3M
ROIV
Roivant Sciences Ltd.
Nov 19, 2025
Sale(S)
Indirect
850K shares at avg. $20.25$17.2M
ROIV
Roivant Sciences Ltd.
Nov 19, 2025
Sale(S)
Indirect
150K shares at avg. $20.20$3.0M
ROIV
Roivant Sciences Ltd.
Nov 19, 2025
Sale(S)
Indirect
175K shares at avg. $20.24$3.5M
ROIV
Roivant Sciences Ltd.
Nov 19, 2025
Sale(S)
Indirect
125K shares at avg. $20.16$2.5M
ROIV
Roivant Sciences Ltd.
Sep 10, 2025
Award(A)
Direct
14.5K shares-
ROIV
Roivant Sciences Ltd.
Jun 25, 2025
Other(J)
Indirect
6.2M shares-
ROIV
Roivant Sciences Ltd.
Jun 25, 2025
Other(J)
Indirect
1.2M shares-
ROIV
Roivant Sciences Ltd.
Jun 25, 2025
Other(J)
Indirect
3.2M shares-
ROIV
Roivant Sciences Ltd.
Jun 25, 2025
Other(J)
Indirect
6.8M shares-
ROIV
Roivant Sciences Ltd.
Sep 25, 2024
Sale(S)
Direct
134.9K shares at avg. $11.77$1.6M
ROIV
Roivant Sciences Ltd.
Sep 24, 2024
Sale(S)
Direct
368.1K shares at avg. $11.63$4.3M
ROIV
Roivant Sciences Ltd.
Sep 10, 2024
Award(A)
Direct
16.4K shares-

		Type	Shares	Price		Ownership
Sep 16, 2026	ROIV Roivant Sciences Ltd.	Award(A)	5,054	-	$0	Direct
Feb 13, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	225,000	$26.50	$5,962,500	Indirect
Feb 13, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	150,784	$26.49	$3,994,268	Indirect
Feb 12, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	275,000	$26.76	$7,359,000	Indirect
Feb 12, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	150,000	$26.72	$4,008,000	Indirect
Feb 11, 2026	ROIV Roivant Sciences Ltd.	Sale(S)	425,000	$26.67	$11,334,750	Indirect
Dec 17, 2025	ROIV Roivant Sciences Ltd.	Sale(S)	155,076	$23.02	$3,569,850	Indirect
Dec 17, 2025	ROIV Roivant Sciences Ltd.	Sale(S)	432,718	$23.05	$9,974,150	Indirect
Dec 17, 2025	ROIV Roivant Sciences Ltd.	Sale(S)	189,538	$23.17	$4,391,595	Indirect
Dec 16, 2025	ROIV Roivant Sciences Ltd.	Sale(S)	642,282	$23.08	$14,823,869	Indirect
Dec 16, 2025	ROIV Roivant Sciences Ltd.	Sale(S)	275,000	$22.93	$6,305,750	Indirect
Nov 19, 2025	ROIV Roivant Sciences Ltd.	Sale(S)	850,000	$20.25	$17,212,500	Indirect
Nov 19, 2025	ROIV Roivant Sciences Ltd.	Sale(S)	150,000	$20.20	$3,030,000	Indirect
Nov 19, 2025	ROIV Roivant Sciences Ltd.	Sale(S)	175,000	$20.24	$3,542,000	Indirect
Nov 19, 2025	ROIV Roivant Sciences Ltd.	Sale(S)	125,000	$20.16	$2,520,000	Indirect
Sep 10, 2025	ROIV Roivant Sciences Ltd.	Award(A)	14,524	-	-	Direct
Jun 25, 2025	ROIV Roivant Sciences Ltd.	Other(J)	6,205,368	-	-	Indirect
Jun 25, 2025	ROIV Roivant Sciences Ltd.	Other(J)	1,170,646	-	-	Indirect
Jun 25, 2025	ROIV Roivant Sciences Ltd.	Other(J)	3,176,245	-	-	Indirect
Jun 25, 2025	ROIV Roivant Sciences Ltd.	Other(J)	6,837,266	-	-	Indirect
Sep 25, 2024	ROIV Roivant Sciences Ltd.	Sale(S)	134,948	$11.77	$1,587,704	Direct
Sep 24, 2024	ROIV Roivant Sciences Ltd.	Sale(S)	368,052	$11.63	$4,278,605	Direct
Sep 10, 2024	ROIV Roivant Sciences Ltd.	Award(A)	16,406	-	$0	Direct

1-23 of 23 transactions

About MANCHESTER KEITH S

MANCHESTER KEITH S (SEC CIK 0001244828) files insider reports with the SEC as Director of Roivant Sciences Ltd. (ROIV).

Signal8 holds 8 ownership filings by MANCHESTER KEITH S, all Form 4s, filed between Sep 12, 2024 and Sep 18, 2026. Those filings report 23 transactions, from Sep 10, 2024 to Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MANCHESTER KEITH S's filings is in LONDON.

Recent filings by MANCHESTER KEITH S

Sep 16, 2026: Grant or award of ROIV shares (Form 4, code A).
Feb 13, 2026: Open-market sales of ROIV shares (2 lines, Form 4, code S).
Feb 12, 2026: Open-market sales of ROIV shares (2 lines, Form 4, code S).
Feb 11, 2026: Open-market sale of ROIV shares (Form 4, code S).
Dec 17, 2025: Open-market sales of ROIV shares (3 lines, Form 4, code S).

Other insiders filing for Roivant Sciences Ltd. (ROIV)

Venker Eric, President & Immunovant CEO
Oren Ilan, Director
Epperly Melissa B,, Director
MOMTAZEE JAMES C, Director
Sukhatme Mayukh, President & CIO
Gline Matthew, CEO

How to read Form 4 transaction codes